Sterile Pharmaceutical Manufacturing (WATER FOR INJECTION, USP)

The contract pertains to the manufacture and packaging of sterile water for injection in 1000mL plastic bags, strictly adhering to USP, FDA, and DLA standards to ensure pharmaceutical quality and safety. The product must be produced under controlled sterile conditions and meet all regulatory requirements for parenteral use, with packaging in compliant plastic bags that maintain sterility and integrity throughout distribution and use. The work is designated as a subcontract under NAICS code 325412, specifically for pharmaceutical manufacturing, and is tied to the Department of Defense through the Medical Supply Chain Pharm FSA. The solicitation was posted on July 30, 2026, with a response deadline of August 5, 2026, indicating a tight turnaround for qualified manufacturers to submit proposals. Performance of the contract is required at Fort Bragg, North Carolina, with a zip code of 28310, suggesting direct logistical coordination with military medical supply operations. The contract does not specify a set-aside type, meaning it is open to all eligible subcontractors regardless of business size or ownership status. All submissions must align with the defense supply chain’s stringent quality and compliance protocols to support critical medical needs within the DoD healthcare system.